Andrew is an innovative, results-driven executive with significant experience leading strategic, financial and operations teams in life sciences and technology companies in the biotech, medical device, diagnostic, digital health, and manufacturing sectors, ranging from Fortune 50 to venture-backed start-ups.

Andrew is currently a partner at FLG Partners. FLG Partners is a financial consulting and advisory practice of experienced CFOs delivering to CEOs and Boards, high-value, interim and permanent leadership – exclusively at the C-level.

Prior to joining FLG, Andrew founded Finategy, a strategic advisory firm that provided C-suite and strategic advisory services to Private Equity & Venture backed companies and Merck’s Global Health Innovation fund.

Prior to consulting, Andrew spent 16 years at Merck in strategic, operational, finance, and marketing roles of increasing responsibility. Andrew’s final role at Merck was Senior Director, Global Scientific Strategy – Portfolio Management, and chair of the Research divisions capital committee.

Back to company leadership